Back

IN VITRO SURVEILLANCE OF ERAVACYCLINE AGAINST GRAM-POSITIVE PATHOGENS, INCLUDING RESISTANT ISOLATES, COLLECTED WORLDWIDE DURING 2020

April 26, 2022